Common and rare alleles as causes of complex phenotypes

Current Atherosclerosis Reports

Volumn 10, Issue 3, 2008, Pages 194-200

  Polychronakos, Constantin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA ANTIGEN; HLA DQB1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; MELANOCORTIN 4 RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SULFONYLUREA DERIVATIVE;

ALLELE; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG RESPONSE; EFFECT SIZE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PREDICTION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; DYSLIPIDEMIA; GENETIC HETEROGENEITY; GENETICS; GENOMICS; MULTIFACTORIAL INHERITANCE; MUTATION; QUANTITATIVE TRAIT;

DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC RESEARCH; GENOMICS; HUMANS; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; MUTATION; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE; RISK FACTORS;

EID: 49949094588     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-008-0031-1     Document Type: Review

References (34)

1. On-line Mendelian Inheritance in Man, statistics page. Available at http://www.ncbi.nlm.nih.gov/Omim/mimstats.html. Accessed December 15, 2007.
2. Cooke GS, Hill AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001, 2:967-977.
3. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. N Engl J Med 1990, 322:1483-1487.
4. Henkin L, Bergman RN, Bowden DW, et al.: Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003, 13:211-217.
5. Permutt MA, Wasson J, Cox N: Genetic epidemiology of diabetes. J Clin Invest 2005, 115:1431-1439.
6. O'Connell DL, Heller RF, Roberts DC, et al.: Twin study of genetic and environmental effects on lipid levels. Genet Epidemiol 1988, 5:323-341.
7. Concannon P, Erlich HA, Julier C, et al.; Type 1 Diabetes Genetics Consortium: Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54:2995-3001.
8. Barratt BJ, Payne F, Lowe CE, et al.: Remapping the insulin gene/ IDDM2 locus in type 1 diabetes. Diabetes 2004, 53:1884-1889.
9. Nakhla M, Polychronakos C: Monogenic and other unusual causes of diabetes mellitus. Pediatr Clin North Am 2005, 52:1637-1650.
10. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, et al.: HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A 2002, 99:4614-4619.
11. Redon R, Ishikawa S, Fitch KR, et al.: Global variation in copy number in the human genome. Nature 2006, 444:444-454.
12. International HapMap Consortium, Frazer KA, Ballinger DG, Cox DR, et al.: A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
13. Fan JB, Chee MS, Gunderson KL: Highly parallel genomic assays. Nat Rev Genet 2006, 7:632-644.
14. Pritchard JK: Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001, 69:124-137.
15. Ahituv N, Kavaslar N, Schackwitz W, et al.: Medical sequencing at the extremes of human body mass. Am J Hum Genet 2007, 80:779-791.
16. Kryukov GV, Pennacchio LA, Sunyaev SR: Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007, 80:727-739.
17. Neel JV: Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962, 14:353-362.
18. Vang T, Congia M, Macis MD, et al.: Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005, 37:1317-1319.
19. Voight BF, Kudaravalli S, Wen X, Pritchard JK: A map of recent positive selection in the human genome. PLoS Biol 2006, 4:e72.
20. Levy S, Sutton G, Ng PC, et al.: The diploid genome sequence of an individual human. PLoS Biol 2007 5:e254.
21. Cohen JC, Kiss RS, Pertsemlidis A, et al.: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004, 305:869-872.
22. Brooks-Wilson A, Marcil M, Clee SM, et al.: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345.
23. PolyPhen: prediction of functional effect of human nsSNPs. Available at http://genetics.bwh.harvard.edu/pph/. Accessed December 18, 2007.
24. Vaisse C, Clement K, Guy-Grand B, Froguel P: A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998, 20:113-114.
25. Dubern B, Clément K, Pelloux V, et al.: Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr 2001, 139:204-209.
26. Miesenbock G, Holzl B, Foger B, et al.: Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993, 91:448-455.
27. Wang J, Cao H, Ban MR, et al.: Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler Thromb Vasc Biol 2007, 27:2450-2455.
28. Ropers HH: New perspectives for the elucidation of genetic disorders. Am J Hum Genet 2007, 81:199-207.
29. Weng L, Kavaslar N, Ustaszewska A, et al.: Lack of MEF2A mutations in coronary artery disease. J Clin Invest 2005, 115:1016-1020.
30. Sladek R, Rocheleau G, Rung J, et al.: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
31. Zeggini E, Weedon MN, Lindgren CM, et al.; Wellcome Trust Case Control Consortium (WTCCC): Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
32. Saxena R, Voight BF, Lyssenko V, et al.; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
33. Scott LJ, Mohlke KL, Bonnycastle LL, et al.: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345
34. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al.: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39:770-775.